Edition:
United States

Leap Therapeutics Inc (LPTX.OQ)

LPTX.OQ on NASDAQ Stock Exchange Global Market

6.83USD
4:00pm EDT
Change (% chg)

$0.01 (+0.15%)
Prev Close
$6.82
Open
$6.85
Day's High
$6.96
Day's Low
$6.83
Volume
2,712
Avg. Vol
11,737
52-wk High
$10.25
52-wk Low
$4.94

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.501
Mar '18 0.00 -0.853
FY 2017 Dec '17 0.00 -1.643
Sep '17 0.00 -0.725
Jun '17 0.00 -0.735
Mar '17 0.00 -1.391
FY 2016 Dec '16 0.00 -0.610
Sep '16 0.00 -0.774
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 3 -0.45 -0.39 -0.49 -0.71
Quarter Ending Dec-18 3 -0.47 -0.41 -0.52 -0.79
Year Ending Dec-18 3 -2.21 -2.03 -2.32 -3.09
Year Ending Dec-19 3 -1.67 -1.38 -1.85 -2.63
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.67 30.17
P/E High - Last 5 Yrs. -- 268.68 47.22
P/E Low - Last 5 Yrs. -- 94.38 24.76
Beta -- 0.78 0.85
Price to Sales (TTM) -- 251.80 7.96
Price to Book (MRQ) 8.40 12.51 3.68
Price to Tangible Book (MRQ) 8.63 22.18 5.57
Price to Cash Flow (TTM) -- 61.34 20.80
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.38 1.79
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.50 -6.02
Payout Ratio(TTM) -- 6.29 46.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 157.04 7.11
Sales (TTM) vs TTM 1 Yr. Ago -- 90.91 11.85
Sales - 5 Yr. Growth Rate -- 24.11 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.82 91.80 23.72
EPS (TTM) vs TTM 1 Yr. Ago -6.06 -- --
EPS - 5 Yr. Growth Rate -- 23.11 7.49
Capital Spending - 5 Yr. Growth Rate -- 36.56 8.05

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.50
Current Ratio (MRQ) 5.32 5.43 3.54
LT Debt to Equity (MRQ) 0.00 19.83 11.28
Total Debt to Equity (MRQ) 0.00 23.67 14.23
Interest Coverage (TTM) -36.93 -188.31 32.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 58.15 55.18
Gross Margin - 5 Yr. Avg. -- 52.69 53.35
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -191.22 15.81
Operating Margin (TTM) -- -1,104.16 -2.55
Operating Margin - 5 Yr. Avg. -- -204.63 10.94
Pre-Tax Margin (TTM) -- -989.95 -0.67
Pre-Tax Margin - 5 Yr. Avg. -- -205.61 11.10
Net Profit Margin (TTM) -- -981.23 -3.87
Net Profit Margin - 5 Yr. Avg. -- -203.21 7.45
Effective Tax Rate (TTM) -- 12.10 20.32
Effective Tax Rate - 5 Yr. Avg. -- 18.73 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,056,061 723,095,676
Net Income/Employee (TTM) -- -5,576,115 84,116,797
Receivable Turnover (TTM) -- 6.52 5.40
Inventory Turnover (TTM) -- 2.27 3.53
Asset Turnover (TTM) 0.00 0.43 0.84

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -149.45 2.18 10.09
Return on Assets - 5 Yr. Avg. -- 2.43 10.96
Return on Investment (TTM) -182.72 3.33 12.67
Return on Investment - 5 Yr. Avg. -- 1.79 14.16
Return on Equity (TTM) -280.09 2.31 14.86
Return on Equity - 5 Yr. Avg. -- -7.00 15.52
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -65.18 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Leap Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 62.52%
# of Holders: 25
Total Shares Held: 9,191,084
3 Mo. Net Change: 175,957
# New Positions: 4
# Closed Positions: 3
# Increased Positions: 16
# Reduced Positions: 5
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.